title: High incidence of fistula formation during bevacizumab treatment in rectal cancer patients.
authors.forename: Ido
authors.initials: I
authors.lastname: Wolf
authors.forename: Damien
authors.initials: D
authors.lastname: Urban
authors.forename: Raphael
authors.initials: R
authors.lastname: Pfeffer
authors.forename: Raphael
authors.initials: R
authors.lastname: Catane
authors.forename: Dan
authors.initials: D
authors.lastname: Aderka
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012003:Rectal Fistula / Q000139:chemically induced* / Q000000981:diagnostic imaging; D012004:Rectal Neoplasms / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab